School of Medicine


Showing 1-50 of 418 Results

  • Bruce T. Adornato

    Bruce T. Adornato

    Adjunct Clinical Professor, Adult Neurology

    BioDr. Adornato joined the Department of Neurology as Voluntary Clinical Faculty in 1978, (subsequently Adjunct Clinical Faculty) and has served as Director of the Neuromuscular Laboratory from 1978 until 1983, performing and interpreting nerve and muscle biopsies as well as serving as attending physician directing residents and medical students in the diagnosis and care of his private patients admitted to Stanford Hospital. Since 1986, he has been attending physician at the Palo Alto VA Hospital, directing Stanford Neurology residents and medical students in the care of veterans. He has published 69 peer reviewed papers and a number of book chapters in the field of neurology. He is currently the medical officer of a silicon valley startup exploring mobility devices for the neurologically impaired.

  • Gregory W. Albers, MD

    Gregory W. Albers, MD

    Coyote Foundation Professor and Professor, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsOur group’'s research focus is the acute treatment and prevention of cerebrovascular disorders. Our primary interest is the use of advanced imaging techniques to expand the treatment window for ischemic stroke. We are also conducting clinical studies of both neuroprotective and thrombolytic strategies for the treatment of acute stroke and investigating new antithrombotic strategies for stroke prevention.

  • Katrin Andreasson

    Katrin Andreasson

    Edward F. and Irene Thiele Pimley Professor of Neurology and Neurological Sciences

    Current Research and Scholarly InterestsOur research focuses on understanding how immune responses initiate and accelerate synaptic and neuronal injury in age-related neurodegeneration, including models of Alzheimer's disease and Parkinson's disease. We also focus on the role of immune responses in aggravating brain injury in models of stroke. Our goal is the identification of critical immune pathways that function in neurologic disorders and that can be targeted to elicit disease modifying effects.

  • Meredith Barad, MD

    Meredith Barad, MD

    Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine
    Clinical Associate Professor (By courtesy), Adult Neurology

    Current Research and Scholarly InterestsMy current research interests involve novel treatment paradigms for challenging pain problems such as orofacial pain, trigeminal neuralgia and low pressure headaches. I am also interested in migraine and trigeminal autonomic cephalgias and their intersection with chronic pain.

  • Richard Baron, MD

    Richard Baron, MD

    Clinical Assistant Professor, Adult Neurology
    Clinical Assistant Professor (By courtesy), Otolaryngology (Head and Neck Surgery)

    BioDr. Baron is a board-certified, fellowship-trained neurologist in the Stanford Health Care Headache Clinic and the Vestibular Balance Disorders Program. He is also clinical assistant professor in the Department of Neurology & Neurological Sciences and, by courtesy, in the Department of Otolaryngology – Head & Neck Surgery at Stanford University School of Medicine. He received fellowship training in both headache medicine and otoneurology (dizziness and vestibular disorders) at Stanford University School of Medicine.

    He specializes in diagnosing, managing, and treating the many causes of headache, facial pain, and dizziness. To provide the highest level of care, he takes a detailed history, performs a specialized physical exam, and collaborates with colleagues across the Stanford Health Care system. Dr. Baron develops a comprehensive care plan customized for each patient. He specializes in non-medication options, nerve blocks and other advanced treatments, Botox® injections, and the latest headache medications and devices.

    Dr. Baron has a particular interest in the management of idiopathic intracranial hypertension (IIH), which results from pressure around the brain and causes headaches and problems with vision. He has established a multidisciplinary group of Stanford Health Care doctors to improve and coordinate care for people with IIH. The group includes doctors from several departments, including neuro-ophthalmology, neurosurgery, interventional radiology, and bariatric surgery and medical weight loss. They work together to determine the most effective medical and procedural treatments.

    Dr. Baron also has a strong interest in the evaluation of acute vestibular syndromes and the management of dizziness in the emergency room. He has published in Journal of the Neurological Sciences, Otolaryngologic Clinics of North America, and Translational Behavioral Medicine. He has also written several chapters for the Stanford Neurology Resident Handbook. He has presented his research at conferences throughout the United States, and he is heavily involved with quality improvement projects and educating resident physicians.

    Dr. Baron is a member of the American Headache Society, American Academy of Neurology, Catholic Medical Association, and Alpha Omega Alpha Honor Medical Society.

  • Shawn Barton, MD, PhD

    Shawn Barton, MD, PhD

    Instructor, Adult Neurology

    BioDr. Shawn Barton is a board-certified, fellowship-trained neurologist with the Stanford Health Care Movement Disorders Center. He is also a clinical instructor in the Department of Neurology & Neurological Sciences at Stanford University School of Medicine.

    Dr. Barton specializes in movement disorders, such as Parkinson’s disease, essential tremor, and dystonia. With a deep understanding of neuroscience, he expertly diagnoses and treats many neurodegenerative and genetic conditions. He provides compassionate care focused on relieving symptoms and improving everyday life.

    During his doctoral studies, Dr. Barton investigated drug delivery and the development of novel biomarkers in Alzheimer’s disease using preclinical mouse models. As a physician-scientist, his research interests include identifying biomarkers for Parkinson's disease and other neurodegenerative diseases. He also focuses on developing clinical trials to advance potential disease-modifying therapies.

    Dr. Barton has published his findings in several peer-reviewed journals, including Science, Journal of Alzheimer’s Disease, and Journal of Biomolecular NMR. He also has presented at national conferences, including annual meetings of the American Academy of Neurology and the Society of General Internal Medicine. He has shared his research on a range of topics, including identifying methods of increasing blood-brain barrier penetrance for therapeutic delivery and using inhaled fluorescent markers to detect amyloid-beta plaques (a protein known to build up in the brain with Alzheimer’s disease) in the retina.

    Dr. Barton is a member of the American Academy of Neurology, American Neurological Association, and International Parkinson and Movement Disorder Society.

  • Fiona Baumer

    Fiona Baumer

    Assistant Professor of Neurology (Pediatric Neurology)

    Current Research and Scholarly InterestsCauses of Disturbed Cognition in Pediatric Epilepsy

  • Ritwik Bhatia, MD

    Ritwik Bhatia, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Bhatia is a board-certified, fellowship-trained neurologist with Stanford Health Care and a clinical assistant professor in the Department of Neurology and Neurological Sciences, Division of Neurocritical Care at Stanford University School of Medicine.

    Dr. Bhatia joined Stanford in 2024 after completing Neurocritical Care fellowship at the University of California, San Francisco. He provides critical care to patients following acute neurological injuries, such as stroke, traumatic brain injury, intracranial hemorrhage, and other disorders affecting the brain, spinal cord, and nervous system. He strives to provide excellent patient care in multidisciplinary teams. He enjoys teaching and is the physician lead for simulation for Advanced Practice Providers in Neurocritical Care. He currently serves as the Unit Based Medical Director for the Neurosciences ICU at Stanford Hospital, leading the unit's initiatives in quality and patient safety.

    Dr. Bhatia’s research interests include longitudinal outcomes for patients with moderate-severe acute acquired brain injury requiring intensive care unit admission. He is developing a neurointensive care recovery clinic at Stanford Healthcare to follow these patients through transitions of care and support neurorecovery.

    Dr. Bhatia has published in several peer-reviewed journals, including Neurology, Journal of Neurosurgery, and Stroke. He has presented at national meetings for the American Academy of Neurology, Society of Vascular and Interventional Neurology, and American Epilepsy Society. He has served as a guideline ambassador for the American Heart Association and is a member of the Neurorecovery Clinic Section of the Neurocritical Care Society. In his spare time, he enjoys spending time with family and friends.

  • MacKenzie Bolen

    MacKenzie Bolen

    Postdoctoral Scholar, Neurology and Neurological Sciences

    BioDr. MacKenzie “Mack” Bolen’s defining research passion is to leverage accessible and modifiable lifestyle factors to mitigate neurodegenerative risk. During her undergraduate education at Austin College in Texas, she began pursuing her interest in neurodegeneration by conducting research focused on the neuroprotective benefits of the ketogenic diet. This work evolved into an honors thesis investigating markers of inflammation in saliva from contact sport athletes and culminated in a TEDx talk on sports-related brain injuries. These experiences cemented her desire to understand the minutiae of the brain and catalyzed her decision to pursue a Ph.D. in Neuroscience at the University of Florida (UF). During Mack’s training under Dr. MG. Tansey at UF, her dissertation work generated global collaborations centered on a multiomic approach that leverages machine learning to identify peripheral biomarkers and novel therapeutic targets to slow the onset or progression of Parkinson’s disease. A hallmark of Mack’s career has been participating in collaborative team science and mentorship of the next generation of scientists, where she has consistently mentored advanced and budding scientists within the Gainesville community and collaborated on several manuscripts from labs across the nation. In addition to her scholarly work, she regularly volunteered at the UF Neuromedicine Intensive Care Unit (Neuro ICU) while pursuing her Ph.D. to better understand the clinical perspective of neurodegeneration.

    By blending her Ph.D. training and experiences in the Neuro ICU, Mack hopes to actively improve the treatment of individuals living with neurodegeneration and continue to push the frontier of medicine as a postdoctoral scholar in Neurology and Neurological Sciences at Stanford. Now under the mentorship of Dr. K. Poston, Mack will continue to access essential training at the intersection of immunology and Parkinson’s disease, via the investigation of the gut-brain axis. As a former collegiate soccer player, Mack loves to pretend to relive her glory days during rec-league on the weekends and can also be found struggling through a Yin yoga class.

  • Helen Bronte-Stewart, MD, MS

    Helen Bronte-Stewart, MD, MS

    John E. Cahill Family Professor, Professor of Neurology and Neurological Sciences (Adult Neurology) and, by courtesy, of Neurosurgery

    Current Research and Scholarly InterestsMy research focus is human motor control and brain pathophysiology in movement disorders. Our overall goal is to understand the role of the basal ganglia electrical activity in the pathogenesis of movement disorders. We have developed novel computerized technology to measure fine, limb and postural movement. With these we are measuring local field potentials in basal ganglia nuclei in patients with Parkinson's disease and dystonian and correlating brain signalling with motor behavior.

  • Axel Brunger

    Axel Brunger

    Professor of Molecular and Cellular Physiology, of Neurology and Neurological Sciences, of Photon Science and, by courtesy, of Structural Biology

    Current Research and Scholarly InterestsOne of my primary goals is to elucidate the molecular mechanisms of synaptic neurotransmitter release by conducting imaging and single-molecule/particle reconstitution experiments, in conjunction with near-atomic resolution structural studies of the synaptic vesicle fusion machinery.

  • Paul Buckmaster, DVM, PhD

    Paul Buckmaster, DVM, PhD

    Professor of Comparative Medicine and of Neurology and Neurological Sciences

    Current Research and Scholarly InterestsMechanisms of epilepsy, especially temporal lobe epilepsy.

  • Marion S. Buckwalter, MD, PhD

    Marion S. Buckwalter, MD, PhD

    Professor of Neurology and Neurological Sciences (Adult Neurology) and of Neurosurgery

    Current Research and Scholarly InterestsThe goal of the Buckwalter Lab is to improve how people recover after a stroke. We use basic and clinical research to understand the cells, proteins, and genes that lead to successful recovery of function, and also how complications develop that impact quality of life after stroke. Ongoing projects are focused on understanding how inflammatory responses are regulated after a stroke and how they affect short-term brain injury and long term outcomes like dementia and depression.

  • Toni Qian Cao, MD

    Toni Qian Cao, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Toni Qian Cao is a board-certified, fellowship-trained neuro-oncologist with Stanford Health Care.

    Dr. Cao specializes in caring for brain and spine tumors, including low grade glioma and glioblastoma. She also has expertise in cancer that has spread (metastasized) to parts of the central nervous system (CNS), such as the brain and the tissues that surround the brain and spinal cord (leptomeninges). She is committed to providing the highest quality care while prioritizing the goals and needs of her patients. She offers compassionate treatment and cancer management, with deep knowledge of tumor therapies and neurological complications of cancer.

    Dr. Cao’s research focuses on improving the identification and treatment of brain tumors and metastases. She has investigated factors that impact the development of brain metastases from breast cancer, as well as treatment for leptomeningeal metastases from breast cancer. She has studied combination treatments for glioblastoma, a type of malignant brain tumor. She is also interested in novel neuroimaging techniques for both primary and metastatic CNS tumors.

    Dr. Cao has published her research in peer-reviewed journals, including Journal of Neuro-Oncology; Neurology; and the International Journal of Radiation Oncology, Biology, Physics. She has also written a book chapter on common early symptoms of CNS metastases.

    Dr. Cao has presented her findings nationally at annual meetings of the American Academy of Neurology, American Society of Clinical Oncology, and Society for Neuro-Oncology. She has also spoken on panels and at regional conferences, including the Annual NeuroTech Convention of Society for Brain Mapping and Therapeutics.

    Dr. Cao is a member of the American Academy of Neurology, American Society of Clinical Oncology, and Society for Neuro-Oncology.

  • Mishu Chandra

    Mishu Chandra

    Clinical Assistant Professor, Adult Neurology

    BioDr. Chandra is clinical assistant professor in the divisions of Comprehensive Neurology and Epilepsy in the Department of Neurology and Neurological Sciences at Stanford University School of Medicine. She is board-certified in Neurology, Clinical Neurophysiology, and Epilepsy.

    A Bay Area native, Dr. Chandra completed her undergraduate education at the University of California, Berkeley. She earned her medical degree from Rush University Medical College and completed her neurology residency at the University of Texas Southwestern Medical Center (UTSW), where she served as the Academic Chief Resident. She pursued her passion for medical education by founding the Clinician Educator Track for the residency program, and continued to serve as Course Director during her fellowship training in both Clinical Neurophysiology and Epilepsy at UTSW. Dr. Chandra later served as an Associate Program Director for the Neurology residency program. Her clinical and research interests include psychiatric disorders in refractory epilepsy, perioperative management of refractory epilepsy requiring surgical intervention, women’s health in neurology, as well as medical education in clinical neurophysiology.

  • Felix Chang, MD

    Felix Chang, MD

    Clinical Assistant Professor, Adult Neurology

    BioDr. Felix Chang's clinical practice mainly involves intraoperative neurophysiologic monitoring (IONM) and the treatment of neurological disorders with botulinum toxin. He earned his medical degree at the University of Texas Southwestern Medical Center. He completed his neurology residency at the Harvard Neurology Program at the Beth Israel Deaconess Medical Center in Boston. He then went on to complete a fellowship in clinical neurophysiology with a focus in intraoperative neurophysiologic monitoring at Stanford.

  • Steven D. Chang, MD

    Steven D. Chang, MD

    Robert C. and Jeannette Powell Neurosciences Professor and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology and Neurological Sciences

    Current Research and Scholarly InterestsClinical research includes studies in the treatment of cerebrovascular disorders, such as aneurysms and AVMs, as well as the use of radiosurgery to treat tumors and vascular malformations of the brain and spine.

    Dr. Chang is C0-Director of the Cyberknife Radiosurgery Program.

    Dr. Chang is also the head of the The Stanford Neuromolecular Innovation Program with the goal of developing new technologies to improve the diagnosis and treatment of patients affected by neurological conditions.

  • Steven Z. Chao

    Steven Z. Chao

    Clinical Professor (Affiliated), Adult Neurology
    Staff, Neurology Research

    BioDr. Steven Chao graduated from UCLA in biochemistry with highest honors, Summa Cum Laude. He then finished his combined MD/PhD training program from Chicago Medical School/Rosalind Franklin University with AOA Honors. Following his neurology residency at Stanford, he continued with a behavior neurology fellowship training at UCSF Memory and Aging Center, where he started research in dementia.

    Currently, He serves as a staff neurologist at the Palo Alto VA and with an appointment at the Stanford Department of Neurology as a clinical professor (affiliated). His current research interest is in early imaging diagnosis of dementia and early treatment/prevention of Alzheimer’s disease, cognitive treatment in traumatic brain injury, and alternative treatments for headache.

    Community and academic education about dementia and cognitive health has always been his passion, and he continues to publish research articles and book chapters to support clinical education.

  • Gaurav Mohit Chattree

    Gaurav Mohit Chattree

    Instructor, Adult Neurology

    BioDr. Chattree is a board-certified neurologist with the Stanford Movement Disorders Center and an Instructor in the Department of Neurology and Neurological Sciences. He provides comprehensive care for patients with movement disorders, which includes deep brain stimulation evaluation/programming and botulinum toxin injections. In addition to his clinical practice, Dr. Chattree conducts research in the lab of Dr. Mark Schnitzer at Stanford, where he uses optical and genetic techniques in mice to develop new treatments for movement disorders.

  • S. Charles Cho, MD

    S. Charles Cho, MD

    Clinical Professor, Adult Neurology
    Clinical Professor (By courtesy), Neurosurgery

    Current Research and Scholarly InterestsClinical research focused on peripheral nerve and muscle disorders. Also involved with prevention of cerebrovascular disesase in the intraoperative setting. Ongoing clincial studies include treatments for Amyotrophic Lateral Sclerosis (ALS), Inflammatory Demyelinating Neuropathy and HIV neuropathic pain.